Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,455 HKD | +5,81% | -4,21% | -54,04% |
Vakgebied
Aantal werknemers: 100
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Development, Production, Marketing and Sale of Medical Products
100,0
%
| 38 | 100,0 % | 92 | 100,0 % | +144,53% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Other Regions
60,1
%
| 29 | 76,4 % | 55 | 60,1 % | +92,43% |
China
39,9
%
| 9 | 23,6 % | 37 | 39,9 % | +313,23% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Xue
CEO | Chief Executive Officer | 55 | 30-01-18 |
Glenn Hassan
DFI | Director of Finance/CFO | 46 | 02-04-19 |
Gerald Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Minnie Ke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Qian Ma
CMP | Compliance Officer | - | 21-06-21 |
Pauline Li
COO | Chief Operating Officer | - | 08-05-22 |
Isabella Zhao
IRC | Investor Relations Contact | - | - |
Zhang Wei
PRN | Corporate Officer/Principal | - | - |
Hu Tianxin
PRN | Corporate Officer/Principal | - | - |
Chris Chen
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 05-07-22 |
James Geraghty
BRD | Director/Board Member | 70 | 18-07-18 |
Peng Kuan Chan
BRD | Director/Board Member | 61 | 11-06-21 |
Lan Hu
BRD | Director/Board Member | 55 | 16-02-22 |
James Xue
CEO | Chief Executive Officer | 55 | 30-01-18 |
Richard Gregory
BRD | Director/Board Member | 66 | 21-04-20 |
53 | - | ||
Kan Chen
BRD | Director/Board Member | 42 | 16-12-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 424 838 320 | 382 362 890 ( 90,00 %) | 0 | 90,00 % |
Bedrijfsgegevens
CANbridge Pharmaceuticals Inc.
Suite 301, 3F, TImeloit No. 17 RongChuang Road
, Beijing
+86 10 8414 8018
http://www.canbridgepharma.comSector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-54,04% | 23,36 mln. | |
+12,24% | 9 mld. | |
-12,75% | 4,96 mld. | |
+42,38% | 4,47 mld. | |
+5,23% | 3,9 mld. | |
+20,51% | 2,45 mld. | |
-19,05% | 2,41 mld. | |
-28,72% | 2,23 mld. | |
+11,13% | 2,02 mld. | |
+3,94% | 1,65 mld. |
- Beurs
- Aandelen
- Koers 1228
- Onderneming CANbridge Pharmaceuticals Inc.